<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="DDAVP preparations; Desmopressin; DDAVP preparations; Desmopressin; DDAVP preparations; Desmopressin; DDAVP preparations; Desmopressin" /><meta name="IX" content="DDAVP preparations; Desmopressin; DDAVP preparations; Desmopressin; DDAVP preparations; Desmopressin; DDAVP preparations; Desmopressin" /><title>DDAVP®: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP4624-ddavp.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP4624-ddavp.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP4624-ddavp.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 07 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP4031-endocrine-system.htm">6 Endocrine system</a> &gt; <a href="PHP4560-hypothalamic-and-pituitary-hormones-and-anti-oestrogens.htm">6.5 Hypothalamic and pituitary hormones and anti-oestrogens</a> &gt; <a href="PHP4620-posterior-pituitary-hormones-and-antagonists.htm">6.5.2 Posterior pituitary hormones and antagonists</a> &gt; <a href="PHP4621-posterior-pituitary-hormones.htm">Posterior pituitary hormones</a> &gt; <a href="PHP4622-desmopressin.htm">DESMOPRESSIN</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP4621-posterior-pituitary-hormones.htm" title="Previous: Posterior pituitary hormones">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP4629-terlipressin-acetate.htm" title="Next: TERLIPRESSIN ACETATE">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1>DESMOPRESSIN</h1><?highlighter on?><div id="pC" class="jN"><div class="cL"><div class="cE"><h3 class="cO">Additional information</h3> <p class="cT"> interactions (<a href="bnf_int795-desmopressin.htm">Desmopressin</a>).</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Indications </h2> <p class="cT">see under Dose</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Cautions </h2> <p class="cT">see under <a title="target-block: Vasopressin cautions" href="PHP4632-vasopressin.htm#PHP4633">Vasopressin</a>; less pressor activity, but still considerable caution in cardiovascular disease and in hypertension (not indicated for nocturnal enuresis or nocturia in these circumstances); elderly (avoid for nocturnal enuresis and nocturia in those over 65 years); also considerable caution in cystic fibrosis; in nocturia and nocturnal enuresis limit fluid intake to minimum from 1 hour before dose until 8 hours afterwards; in nocturia periodic blood pressure and weight checks needed to monitor for fluid overload; <strong>interactions:</strong> Appendix 1 (desmopressin)</p></div> <div class="cG"><div class="cE"><h3 class="cT">Hyponatraemic convulsions</h3> <p class="cT">Patients being treated for primary nocturnal enuresis should be warned to avoid fluid overload (including during swimming) and to stop taking desmopressin during an episode of vomiting or diarrhoea (until fluid balance normal). The risk of hyponatraemic convulsions can also be minimised by keeping to the recommended starting doses and by avoiding concomitant use of drugs which increase secretion of vasopressin (e.g. tricyclic antidepressants)</p></div></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Contra-indications </h2> <p class="cT">cardiac insufficiency and other conditions treated with diuretics; psychogenic polydipsia and polydipsia in alcohol dependence</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Renal impairment </h2> <p class="cT">use with caution; antidiuretic effect may be reduced</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Pregnancy </h2> <p class="cT">small oxytocic effect in third trimester; increased risk of pre-eclampsia</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Breast-feeding </h2> <p class="cT">not known to be harmful</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Side-effects </h2> <p class="cT">fluid retention, and hyponatraemia (in more serious cases with convulsions) on administration without restricting fluid intake; stomach pain, headache, nausea, vomiting, allergic reactions, and emotional disturbance in children also reported; epistaxis, nasal congestion, rhinitis with nasal spray</p></div> </div> <div class="cL"><h2 class="cM">Dose</h2><div class="cR"><ul> <li><p><span class="cK">By mouth</span> (as desmopressin acetate)</p> <p>Diabetes insipidus, treatment, <span class="cP">adult</span> and <span class="cP">child</span> initially 300 micrograms daily (in 3 divided doses); maintenance, 300–600 micrograms daily in 3 divided doses; range 0.2–1.2 mg daily</p> <p>Primary nocturnal enuresis, <span class="cP">adult</span> (under 65 years) and <span class="cP">child</span> over 5 years 200 micrograms at bedtime, only increased to 400 micrograms if lower dose not effective (<strong>important:</strong> see also Cautions); withdraw for at least 1 week for reassessment after 3 months</p> <p>Postoperative polyuria or polydipsia, adjust dose according to urine osmolality</p> </li> <li><p><span class="cK">Sublingually</span> (as desmopressin base)</p> <p>Diabetes insipidus, treatment, <span class="cP">adult</span> and <span class="cP">child</span> initially 180 micrograms daily in 3 divided doses; range 120–720 micrograms daily</p> <p>Primary nocturnal enuresis, <span class="cP">adult</span> (under 65 years) and <span class="cP">child</span> over 5 years 120 micrograms at bedtime, only increased to 240 micrograms if lower dose not effective (<strong>important:</strong> see also Cautions); withdraw for at least 1 week for reassessment after 3 months</p> <p>Polyuria or polydipsia after hypophysectomy, adjust dose according to urine osmolality</p> </li> <li><p><span class="cK">Intranasally</span> (as desmopressin acetate)</p> <p>Diabetes insipidus, diagnosis, <span class="cP">adult</span> and <span class="cP">child</span> 20 micrograms (limit fluid intake to 500 mL from 1 hour before to 8 hours after administration)</p> <p>Diabetes insipidus, treatment, <span class="cP">adult</span> 10–40 micrograms daily (in 1–2 divided doses); <span class="cP">child</span> 5–20 micrograms daily; infants may require lower doses</p> <p>Nocturia associated with multiple sclerosis (when other treatments have failed), <span class="cP">adult</span> (under 65 years) 10–20 micrograms at bedtime (<strong>important: </strong>see also Cautions), dose not to be repeated within 24 hours</p> <p>Renal function testing (empty bladder at time of administration and limit fluid intake to 500 mL from 1 hour before until 8 hours after administration), <span class="cP">adult</span> 40 micrograms; <span class="cP">infant</span> under 1 year 10 micrograms (restrict fluid intake to 50% at next 2 feeds to avoid fluid overload), <span class="cP">child</span> 1–15 years 20 micrograms</p> <p>Mild to moderate haemophilia and von Willebrand's disease, <span class="cP">adult</span> 300 micrograms (one 150-microgram spray into each nostril) 30 minutes before surgery or when bleeding; may be repeated at intervals of 12 hours (or at intervals of at least 3 days if self-administered)</p> <p>Fibrinolytic response testing, <span class="cP">adult</span> 300 micrograms (one 150-microgram spray into each nostril); blood sampled after 1 hour for fibrinolytic activity</p> </li> <li><p><span class="cK">By injection</span> (as desmopressin acetate)</p> <p>Diabetes insipidus, diagnosis (<span class="cK">subcutaneous</span><em> or </em><span class="cK">intramuscular</span> ), <span class="cP">adult</span> and <span class="cP">child</span> 2 micrograms (limit fluid intake to 500 mL from 1 hour before to 8 hours after administration)</p> <p>Diabetes insipidus, treatment (<span class="cK">subcutaneous</span>, <span class="cK">intramuscular</span><em> or </em><span class="cK">intravenous</span> ), <span class="cP">adult</span> 1–4 micrograms daily; <span class="cP">infant</span> and <span class="cP">child</span> 400 nanograms</p> <p>Renal function testing (empty bladder at time of administration and limit fluid intake to 500 mL from 1 hour before until 8 hours after administration) (<span class="cK">subcutaneous</span><em> or </em><span class="cK">intramuscular</span> ), <span class="cP">adult</span> and <span class="cP">child</span> 2 micrograms; <span class="cP">infant</span> 400 nanograms (restrict fluid intake to 50% at next 2 feeds)</p> <p>Mild to moderate haemophilia and  von Willebrand's disease, (<span class="cK">subcutaneous</span><em> or </em><span class="cK">intravenous</span> ), <span class="cP">adult</span> and <span class="cP">child</span> over 1 month 300 nanograms/kg as a single dose immediately before surgery or after trauma; may be repeated at intervals of 12 hours</p> <p>Fibrinolytic response testing, (<span class="cK">subcutaneous</span><em> or </em><span class="cK">intravenous</span> ), <span class="cP">adult</span> and <span class="cP">child</span> 300 nanograms/kg; blood sampled after 20 minutes for fibrinolytic activity</p> <p>Lumbar-puncture-associated headache, consult product literature</p> </li> </ul></div></div> </div><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="PHP4623-desmopressin-acetate-non-proprietary.htm#PHP4623-desmopressin-acetate-non-proprietary" title="Desmopressin acetate">Desmopressin acetate</a></li></ul><div id="PHP4624-ddavp" style="margin: 0 0 0 20px;"><h1 class="title">DDAVP® <span>(<a href="PHP10005-index-of-manufacturers.htm#PHP10141">Ferring</a>)</span><span> <img src="images/pom_l.png" alt="Prescription only medicine" /></span></h1><div class="cU"><p><strong>Tablets</strong>, both scored, desmopressin acetate 100 micrograms, net price 90-tab pack = £44.12; 200 micrograms, 90-tab pack = £88.23. Counselling, fluid intake, see above</p></div><div class="cU"><p><strong>Oral lyophilisates (DDAVP® Melt)</strong>, desmopressin (as acetate) 60 micrograms, net price 100-tab pack = £50.53; 120 micrograms, 100-tab pack = £101.07; 240 micrograms, 100-tab pack = £202.14. Label: 26, counselling,  fluid intake, see above. For sublingual administration</p></div><div class="cU"><p><strong>Intranasal solution</strong>, desmopressin acetate 100 micrograms/mL. Net price 2.5-mL dropper bottle and catheter = £9.72. Counselling, fluid intake, see above</p></div><div class="cU"><p><strong>Injection</strong>, desmopressin acetate 4 micrograms/mL. Net price 1-mL amp = £1.10</p></div></div><ul class="jT"><li><a href="PHP4625-desmomelt.htm#PHP4625-desmomelt" title="DesmoMelt®">DesmoMelt®</a></li><li><a href="PHP4626-desmotabs.htm#PHP4626-desmotabs" title="Desmotabs®">Desmotabs®</a></li><li><a href="PHP4627-desmospray.htm#PHP4627-desmospray" title="Desmospray®">Desmospray®</a></li><li><a href="PHP4628-octim.htm#PHP4628-octim" title="Octim®">Octim®</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP4621-posterior-pituitary-hormones.htm">Previous: Posterior pituitary hormones</a> | <a class="top" href="PHP4624-ddavp.htm#">Top</a> | <a accesskey="]" href="PHP4629-terlipressin-acetate.htm">Next: TERLIPRESSIN ACETATE</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>